Istaroxime是一款潜在“first-in-class”疗法,具有双重作用机制,旨在改善心脏收缩和舒张...查看全文
$Windtree Therapeutics Inc(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-023912 Size: 5 KB 网页链接
$Windtree Therapeutics Inc(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-023910 Size: 5 KB 网页链接
$Windtree Therapeutics Inc(WINT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-21-023835 Act: 34 Size: 10 MB 网页链接
$Windtree疗法(WINT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001437749-21-022373 Act: 34 Size: 8 MB 网页链接
$Windtree疗法(WINT)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-018801 Act: 34 Size: 5 MB 网页链接
$Windtree疗法(WINT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-018781 Act: 34 Size: 4 MB 网页链接
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-015118 Size: 5 KB 网页链接
$Windtree疗法(WINT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-015119 Size: 7 KB 网页链接
$Windtree疗法(WINT)$ 8-K Current report, item 5.07 Accession Number: 0001437749-21-014971 Act: 34 Size: 39 KB 网页链接
$Windtree疗法(WINT)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-011914 Act: 34 Size: 14 MB 网页链接